TIAL1

Nucleolysin TIAR · Q01085 · TIAL1 on Sugi Atlas →

0 patent compounds predicted against TIAL1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TIAL1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas PHASE2COMPLETED
Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer PHASE1/PHASE2COMPLETED
Study Comparing High Cut-off Haemofiltration With Standard Haemofiltration in Acute Renal Failure PHASE1/PHASE2COMPLETED
Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer PHASE2COMPLETED
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria PHASE2COMPLETED
A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. PHASE2COMPLETED
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease PHASE2COMPLETED
Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae PHASE1COMPLETED
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein PHASE1COMPLETED
FAK Inhibitor in Patients With Advanced Solid Tumors PHASE1NOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function nanUNKNOWN
A Study to Assess Variation in Potential Biomarkers in Friedreich Ataxia nanCOMPLETED
Blood-based Biomarkers for the Prognosis of Sports Related Concussion nanCOMPLETED
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Markers in the Diagnosis of TIA nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer nanCOMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Modulation of Steroid Immunosuppression by Alveolar Efferocytosis nanCOMPLETED
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients nanUNKNOWN
Optimal Detection of Atrial Fibrillation in TIA nanCOMPLETED
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System nanCOMPLETED
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss nanRECRUITING
Steroid Treatment of Idiopathic Nephrotic Syndrome nanCOMPLETED
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a TIAL1 binder may also engage these)

ProteinNameSimilarity
P70318 1.000 P70318 →
TIA1 Cytotoxic granule associated RNA binding protein TIA1 1.000 landscape →
P52912 0.995 P52912 →
Q95QV8 0.991 Q95QV8 →
Q9SYG4 0.987 Q9SYG4 →
P42731 0.986 P42731 →
Q4KM14 0.985 Q4KM14 →
Q54BM2 0.985 Q54BM2 →
Q9LQI9 0.985 Q9LQI9 →
PABPC4 Polyadenylate-binding protein 4 0.985 landscape →
Q6CSV3 0.985 Q6CSV3 →
Q640A2 0.984 Q640A2 →
Q0WW84 0.983 Q0WW84 →
P04147 0.983 P04147 →
A2Q848 0.983 A2Q848 →
Q4VXU2 0.983 Q4VXU2 →
Q5R8F7 0.983 Q5R8F7 →
SYNCRIP Heterogeneous nuclear ribonucleoprotein Q 0.983 landscape →
Q6GR16 0.983 Q6GR16 →
Q7TMK9 0.983 Q7TMK9 →
Q98SP8 0.983 Q98SP8 →
Q7TP47 0.982 Q7TP47 →
Q6CDH3 0.982 Q6CDH3 →
O60176 0.982 O60176 →
Q9EPH8 0.982 Q9EPH8 →
Q9H361 0.982 Q9H361 →
Q9LJH8 0.982 Q9LJH8 →
Q74ZS6 0.982 Q74ZS6 →
Q05196 0.982 Q05196 →
Q9M427 0.981 Q9M427 →